Tatsufumi Nakamura Selected Research

Sialyl Lewis X Antigen

4/2002

Increased sialyl Lewis(x) antigen-positive cells mediated by HTLV-1 infection in peripheral blood CD4(+) T lymphocytes in patients with HTLV-1-associated myelopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsufumi Nakamura Research Topics

Disease

16	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 07/2021 - 04/2002
8	Spinal Cord Diseases 07/2021 - 05/2008
5	T-Cell Leukemia (Leukemia, T Cell) 07/2021 - 05/2008
4	Infections 01/2011 - 04/2002
3	Overactive Urinary Bladder (Overactive Bladder) 07/2021 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2017
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2021 - 02/2005
2	Inflammation (Inflammations) 04/2015 - 04/2002
2	Myasthenia Gravis 01/2013 - 01/2003
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Nocturia 04/2019
1	Ataxia (Dyssynergia) 01/2018
1	Neoplasms (Cancer) 12/2017
1	Multiple Sclerosis 12/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Phlebitis 06/2014
1	Thrombosis (Thrombus) 06/2014
1	Central Nervous System Diseases (CNS Diseases) 10/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2008
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 02/2003
1	Churg-Strauss Syndrome (Allergic Angiitis) 02/2003
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 10/2002
1	Kuru 10/2002
1	Stiff-Person Syndrome (Stiff Man Syndrome) 08/2002
1	Nervous System Diseases (Neurological Disorders) 04/2002

Drug/Important Bio-Agent (IBA)

3	prosultiamineIBA 01/2018 - 01/2009
3	LigandsIBA 12/2017 - 04/2002
2	IntegrinsIBA 01/2018 - 01/2008
2	CytokinesIBA 01/2017 - 12/2004
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2002
2	InterferonsIBA 06/2014 - 02/2005
2	Cholinergic ReceptorsIBA 01/2013 - 01/2003
2	AntigensIBA 01/2011 - 02/2005
2	Tacrolimus (Prograf)FDA LinkGeneric 10/2009 - 05/2008
2	SteroidsIBA 05/2008 - 02/2003
1	Type A Botulinum Toxins (Botox)FDA Link 07/2021
1	tocilizumab (atlizumab)FDA Link 03/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 04/2019
1	mirabegronIBA 04/2019
1	CreatinineIBA 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Immune Checkpoint InhibitorsIBA 12/2017
1	Chemotactic FactorsIBA 12/2017
1	CC ChemokinesIBA 12/2017
1	Minocycline (Cyclops)FDA LinkGeneric 12/2017
1	Trans-Activators (Trans-Acting Factor)IBA 12/2017
1	Prednisolone (Predate)FDA LinkGeneric 10/2017
1	ChemokinesIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	ImmunosorbentsIBA 04/2015
1	EnzymesIBA 04/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2014
1	Heparinoids (Heparinoid)IBA 06/2014
1	Hormones (Hormone)IBA 06/2014
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 06/2014
1	AntibodiesIBA 01/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013
1	muskIBA 01/2013
1	LuciferasesIBA 01/2011
1	fucoidanIBA 01/2011
1	Polysaccharides (Glycans)IBA 01/2011
1	AutoantibodiesIBA 10/2009
1	allithiamineIBA 01/2009
1	Sulfhydryl Compounds (Thiols)IBA 01/2009
1	allicinIBA 01/2009
1	DisulfidesIBA 01/2009
1	Thiamine (Aneurin)FDA Link 01/2009
1	Interferon-alpha (Interferon Alfa)IBA 05/2008
1	Monomeric GTP-Binding ProteinsIBA 01/2008
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2007
1	p38 Mitogen-Activated Protein KinasesIBA 02/2005
1	Messenger RNA (mRNA)IBA 12/2004
1	Complement System Proteins (Complement)IBA 01/2003
1	PrionsIBA 10/2002
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2002
1	Interferon-gamma (Interferon, gamma)IBA 04/2002
1	Interleukin-12 (IL 12)IBA 04/2002
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 04/2002
1	CD40 Ligand (CD40L)IBA 04/2002
1	Sialyl Lewis X AntigenIBA 04/2002
1	P-SelectinIBA 04/2002

Therapy/Procedure

4	Therapeutics 07/2021 - 08/2002
1	Injections 07/2021
1	Intravesical Administration 07/2021
1	Aftercare (After-Treatment) 01/2018
1	Immunotherapy 12/2017
1	Liver Transplantation 05/2008
1	Plasma Exchange 08/2002